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Abstract
Background: An association between influenza A viruses and myocarditis was noted during the 1918 influenza
pandemic. Since then, the link between the influenza B virus and fulminant myocarditis or cardiogenic shock has
been rarely reported.
Case presentation: In February 2013, a 50 year-old-woman without known heart disease presented in profound
cardiogenic shock with a left ventricular ejection fraction of 10%. Her presentation was preceded by six days of
fever, chills, myalgia and fatigue. She had a junctional tachycardia, a troponin I of 12.6 ng/ml and her coronary
angiography demonstrated normal coronary arteries. Percutaneous extracorporeal membrane oxygenation was
required. An endotracheal aspirate at admission was positive for influenza B. All other respiratory, blood and urine
cultures were negative. On day 7, a repeat echocardiography demonstrated significant recovery of left ventricular
function with an ejection fraction of 50%. She was later discharged home in good condition.
Conclusions: Influenza B infection can be complicated by fulminant cardiomyopathy leading to cardiogenic shock
in adults without preexisting cardiac disease.
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Background
Myocardial involvement caused by the influenza virus
ranges from mild asymptomatic to fulminant myocar-
ditis or cardiomyopathy resulting in cardiogenic shock
[1-3].
Influenza induced cardiogenic shock is extremely rare
and most reported cases are due to fulminant myocardi-
tis associated with influenza A virus [4-6]. Influenza B
virus infection is generally considered to be mild with
less associated cardiovascular involvement in adults [7].
Here we describe a woman with influenza B who
developed cardiogenic shock with no known pre-existing
heart disease. She was successfully managed with aggres-
sive pharmacological and percutaneous extracorporeal
membrane oxygenation (ECMO) support.
Case presentation
The patient, a 52-year-old healthy woman without a sig-
nificant past medical history, presented to a community
care center complaining of 5 days of productive cough,
diffuse myalgia, and subjective fever with chills. She was
prescribed a course of azithromycin for presumed
bronchitis. The following day, she presented to her local
emergency department with acute onset of severe
shortness of breath and associated chest pain. She was
found to be hypotensive (90/60 mmHg), tachycardic
(115 beats/min), and was admitted to the intensive care
unit (ICU) with a presumptive diagnosis of septic shock.
Norepinephrine and empiric IV vancomycin and pipe-
racillin/tazobactam were started. Initial labs revealed:
white blood cell count (WBC) 12.7/μL with 77.9%
neutrophils, hemoglobin 12.7 g/dl, hematocrit 39.8%, plate-
lets 141, lactate 8.2 mmol/L, sodium (Na) 149 mmol/L,
potassium (K) 4.3 mmol/L, bicarbonate 16 mmol/L, chlo-
ride (Cl) 115, blood urea nitrogen (BUN) 28, creatinine
(Cr) 1.3 mg/dl, blood glucose 214 mg/dl, aspartate amino-
transferase (AST) 128 IU/L, alanine aminotransferase
(ALT) 200, alkaline phosphatase (AP) 104 IU/L, serum
troponin I 12.6 ng/ml, and creatine phosphokinase (CPK)
339 U/L. Her electrocardiogram revealed an accelerated
junctional rhythm with a rate of 115 beats/min, poor R
wave progression and low voltage. An emergent transtho-
racic echocardiogram (TTE) showed severely impaired left
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ventricular (LV) function with an estimated ejection
fraction (EF) of 10%. Within 24 hours of presentation her
condition deteriorated and she required intubation and
mechanical ventilation. The patient then was transferred to
our center for further management.
Upon arrival the patient was intubated, sedated, and
afebrile. Her blood pressure was 70/40 mmHg and she
had a heart rate of 110 beats/min. Examination revealed
bilateral crepitations in the lungs, normal heart sounds
and a benign abdomen. Her skin was mottled; and her
extremities were cold and clammy. There was no pedal
edema. Chest radiograph revealed diffuse bilateral patchy
infiltrates and pulmonary vascular congestion. A repeat
TTE demonstrated a left ventricular ejection fraction of
10%, normal LV and RV dimensions, moderate mitral
regurgitation, left ventricle wall thickness of 12 mm, and
global hypokinesis of LV with minor regional variation.
There was no evidence of a pericardial effusion. Notable
labs were a WBC 14.8/μL with 82% neutrophils, hema-
tocrit 36.5%, platelets 113, CPK 365 U/L, troponin
7.6 ng/ml and Cr 0.76 mg/dl. The patient remained
hypotensive despite maximum doses of norepinephrine,
dobutamine and vasopressin. She was continued on
empiric antibiotics and empiric oseltamivir (75 mg twice
daily) was added. Immediate left and right heart
catheterization demonstrated normal coronary anatomy,
with a cardiac index of 1.16 L/min/m2. Emergent veno-
arterial ECMO (flow = 4 L/min) was placed via left
common femoral vein and artery.
On day 3 of hospitalization, pulmonary congestion
significantly improved but another repeat TTE showed
persistent severe LV systolic dysfunction with an EF of
15%. Endotracheal aspiration at admission returned
positive for influenza B by polymerase chain reaction
(PCR). Right ventricular endomyocardial biopsy was
performed on hospital day 3 (total 4 specimens). Histo-
pathology was negative for inflammation. Immunohisto-
chemical stain for parvovirus B19, HHV6, HSV and PCR
for enteroviruses, EBV and CMV were all negative.
Bronchoscopy revealed mild mucosal erythema with
clear secretions. The bronchoalveolar lavage (BAL) fluid
was negative for enteroviruses, adenoviruse, CMV, EBV
and HSV by PCR. Blood, BAL and urine cultures were
negative for bacterial growth and empiric antimicrobials
were stopped on day 5 and oseltamivir was continued
for a total of 7 days.
The patient’s clinical status gradually improved, ino-
tropic support was stopped and a repeat TTE on day 7
showed significant recovery of left ventricular function
with an estimated EF of 50%, and ECMO support was
able to be withdrawn.
The patient was extubated on hospital day 8; low doses of
a β -blocker and an angiotensin converting enzyme
inhibitor were started. The patient’s course was complicated
by a pseudoaneurysm of the left common femoral artery
secondary to the ECMO therapy, which was repaired suc-
cessfully. She was discharged on hospital day 15. Trans-
thoracic echocardiography one month after discharge
demonstrated normal LV systolic function with an EF of
60%, normal LV wall thickness, trace mitral regurgitation
and no ventricular dilation.
Discussion
During the 1918–1919 influenza pandemic an asso-
ciation between myocarditis and influenza viruses was
noted during an autopsy study [8]. While there have
been reports of fulminant myocarditis or cardiomyop-
athy associated with influenza B in children, it has very
rarely been reported in adults [7,9-11]. In 1958, a group
of four patients with pericarditis, subacute myocarditis,
and fatal chronic myocarditis associated with influenza B
were documented [12]. Ray CG et al. described a 34-
year-old healthy woman who presented with acute onset
of dilated cardiomyopathy and cardiogenic shock follow-
ing a few days of flu like syndrome. She had a very
complicated course and died 6 weeks after the onset of
symptoms. Influenza B virus was isolated from the
nasopharynx and the diagnosis of acute myocarditis was
confirmed by cardiac autopsy [13].
McCarthy et al. described fulminant myocarditis as a
distinct clinical presentation of abrupt onset of severe
heart failure and cardiogenic shock preceded by a viral
syndrome similar to our patient [14]. The typical
echocardiographic findings in fulminant myocarditis are
described as near normal ventricular dimensions,
severely depressed LV systolic function, and increased
left ventricle wall thickness [15]. Histological diagnosis
of fulminant myocarditis can be difficult especially in the
early phase of disease. The limited sensitivity of cardiac
biopsy for detection of myocarditis is well recognized
and negative cardiac biopsies results cannot exclude the
diagnosis of myocarditis [16]. Myocarditis usually pre-
sents as a focal or patchy infiltration predominantly in
the lateral free wall of the left ventricle and often not
involving the right ventricle, therefore, biopsies taken
from the right ventricle could be falsely negative [17].
This patient’s clinical presentation of refractory car-
diogenic shock 6 days after the onset of influenza and
severely impaired left ventricular systolic function, and
subsequent normalization of ventricular function after
recovery of her viral illness; taken together with her
typical echocardiogram findings in the setting of normal
coronaries supports the clinical diagnosis of viral ful-
minant myocarditis; regardless of non diagnostic right
ventricle biopsies. During influenza infection, severe
myocardial dysfunction can be caused not only by direct
injury to cardiac myocytes but also by overexpression of
cytokines and severe inflammatory response to viral
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infection resulting cytokine and humoral mediated forms
of myocarditis with no cellular infiltrate.
The reason for the unexpected severity of influenza B
infection in our patient was not clear. Clinical data about
risk factors and complications of influenza B are limited.
Her only past medical history was remote myasthenia
gravis and thymectomy over 20 years prior. The pre-
dominant circulating B strain was B/Wisconsin/1/2010-
LIKE when the patient presented to the hospital, which
was matched with the B component of the 2012–2013
vaccine [18]. We do not know if the patient had received
an influenza vaccine this season. The possible lack of
immunologic memory for this infection might have
contributed to the severity of influenza B virus infection
in our patient. Increasing awareness among patients and
physicians about the importance of vaccination as the
most important strategy for minimizing the severe com-
plications of influenza infection could help to prevent
similar cases in the future.
The treatment of influenza associated fulminant myo-
carditis still remains supportive. Studies have shown the
early use of mechanical circulatory support for patients
with fulminant myocarditis and cardiogenic shock who
fail aggressive pharmacologic treatment would increase
survival rate [19,20]. Our patient received oseltamivir,
standard heart failure treatment but more important
early initiation of ECMO support before irreversible
organ failure developed.
Conclusions
In conclusion, we report this case to draw attention that
influenza B, which is usually considered less pathogenic,
can unexpectedly be complicated by fulminant myocar-
ditis or cardiomyopathy leading to cardiogenic shock in
adults. Therefore, a multidisciplinary approach including
early initiation of antiviral treatment and aggressive
cardiac support is essential for a favorable outcome.
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